Literature DB >> 28775053

Assessing risk in pulmonary arterial hypertension: what we know, what we don't.

Raymond L Benza1, Harrison W Farber2, Mona Selej3,4, Mardi Gomberg-Maitland5.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28775053     DOI： 10.1183/13993003.01353-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  20 in total

1.  Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.

Authors:  Marius M Hoeper; Tilmann Kramer; Zixuan Pan; Christina A Eichstaedt; Jens Spiesshoefer; Nicola Benjamin; Karen M Olsson; Katrin Meyer; Carmine Dario Vizza; Anton Vonk-Noordegraaf; Oliver Distler; Christian Opitz; J Simon R Gibbs; Marion Delcroix; H Ardeschir Ghofrani; Doerte Huscher; David Pittrow; Stephan Rosenkranz; Ekkehard Grünig
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

Authors:  E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

3.  Validation of a risk assessment instrument for pulmonary arterial hypertension.

Authors:  Jason Weatherald; Olivier Sitbon; Marc Humbert
Journal:  Eur Heart J       Date:  2018-12-14       Impact factor: 29.983

4.  Survivor bias and risk assessment.

Authors:  Dave P Miller; Mardi Gomberg-Maitland; Marc Humbert
Journal:  Eur Respir J       Date:  2012-09       Impact factor: 16.671

5.  Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaïci; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Vincent Cottin; Bruno Degano; Xavier Jaïs; David Montani; Rogério Souza; Gérald Simonneau
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

6.  Survival in pulmonary arterial hypertension patients awaiting lung transplantation.

Authors:  Mardi Gomberg-Maitland; Cherylanne Glassner-Kolmin; Sydeaka Watson; Robert Frantz; Myung Park; Adaani Frost; Raymond L Benza; Fernando Torres
Journal:  J Heart Lung Transplant       Date:  2013-09-25       Impact factor: 10.247

7.  Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Authors:  Brian F Gage; Carl van Walraven; Lesly Pearce; Robert G Hart; Peter J Koudstaal; B S P Boode; Palle Petersen
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

8.  Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

Authors:  Karen M Olsson; Marion Delcroix; H Ardeschir Ghofrani; Henning Tiede; Doerte Huscher; Rudolf Speich; Ekkehard Grünig; Gerd Staehler; Stephan Rosenkranz; Michael Halank; Matthias Held; Tobias J Lange; Juergen Behr; Hans Klose; Martin Claussen; Ralf Ewert; Christian F Opitz; C Dario Vizza; Laura Scelsi; Anton Vonk-Noordegraaf; Harald Kaemmerer; J Simon R Gibbs; Gerry Coghlan; Joanna Pepke-Zaba; Uwe Schulz; Matthias Gorenflo; David Pittrow; Marius M Hoeper
Journal:  Circulation       Date:  2013-09-30       Impact factor: 29.690

9.  Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study.

Authors:  Robert P Frantz; Robert J Schilz; Murali M Chakinala; David B Badesch; Adaani E Frost; Vallerie V McLaughlin; Robyn J Barst; Daniel M Rosenberg; Dave P Miller; Brian K Hartline; Wade W Benton; Harrison W Farber
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

10.  How to develop a more accurate risk prediction model when there are few events.

Authors:  Menelaos Pavlou; Gareth Ambler; Shaun R Seaman; Oliver Guttmann; Perry Elliott; Michael King; Rumana Z Omar
Journal:  BMJ       Date:  2015-08-11
View more
  11 in total

1.  Risk stratification in pulmonary arterial hypertension using Bayesian analysis.

Authors:  Manreet K Kanwar; Mardi Gomberg-Maitland; Marius Hoeper; Christine Pausch; David Pittrow; Geoff Strange; James J Anderson; Carol Zhao; Jacqueline V Scott; Marek J Druzdzel; Jidapa Kraisangka; Lisa Lohmueller; James Antaki; Raymond L Benza
Journal:  Eur Respir J       Date:  2020-08-27       Impact factor: 16.671

Review 2.  The Use of Risk Assessment Tools and Prognostic Scores in Managing Patients with Pulmonary Arterial Hypertension.

Authors:  Manreet Kanwar; Amresh Raina; Lisa Lohmueller; Jidapa Kraisangka; Raymond Benza
Journal:  Curr Hypertens Rep       Date:  2019-04-25       Impact factor: 5.369

3.  Right atrial to left atrial volume index ratio is associated with increased mortality in patients with pulmonary hypertension.

Authors:  Manu M Mysore; Kenneth C Bilchick; Priscilla Ababio; Benjamin K Ruth; William C Harding; Khadijah Breathett; Kimberley Chadwell; Brandy Patterson; Hunter Mwansa; Christiana M Jeukeng; Younghoon Kwon; Jamie L W Kennedy; Andrew D Mihalek; Sula Mazimba
Journal:  Echocardiography       Date:  2018-10-12       Impact factor: 1.724

4.  Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension.

Authors:  Kurt W Prins; Rajat Kalra; Lauren Rose; Tufik R Assad; Stephen L Archer; Navkaranbir S Bajaj; E Kenneth Weir; Sasha Z Prisco; Marc Pritzker; Pamela L Lutsey; Evan L Brittain; Thenappan Thenappan
Journal:  J Am Heart Assoc       Date:  2020-02-21       Impact factor: 5.501

5.  Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension.

Authors:  Raymond L Benza; Manreet K Kanwar; Amresh Raina; Jacqueline V Scott; Carol L Zhao; Mona Selej; C Greg Elliott; Harrison W Farber
Journal:  Chest       Date:  2020-09-01       Impact factor: 9.410

6.  Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Authors:  Marc Humbert; Harrison W Farber; Hossein-Ardeschir Ghofrani; Raymond L Benza; Dennis Busse; Christian Meier; Marius M Hoeper
Journal:  Eur Respir J       Date:  2019-06-05       Impact factor: 16.671

7.  Risk assessment in precapillary pulmonary hypertension: a comparative analysis.

Authors:  Thomas Sonnweber; Eva-Maria Schneider; Manfred Nairz; Igor Theurl; Günter Weiss; Piotr Tymoszuk; Judith Löffler-Ragg
Journal:  Respir Res       Date:  2021-01-21

8.  E-REVEAL Lite 2.0 scoring for early prediction of disease progression in pulmonary arterial hypertension.

Authors:  Sandeep Sahay; Jiken Bhatt; Sarah Beshay; Ashrith Guha; Duc T Nguyen; Edward A Graviss; Sherif F Nagueh
Journal:  Pulm Circ       Date:  2022-01-12       Impact factor: 2.886

9.  Dart to the target: an alternative bull's eye parametric display for European Society of Cardiology / European Respiratory Society goal-orientated risk reduction strategy in pulmonary arterial hypertension.

Authors:  Cihangir Kaymaz; Ozgur Yasar Akbal; Aykun Hakgor; Hacer Ceren Tokgoz; Seda Tanyeri
Journal:  Pulm Circ       Date:  2018-05-16       Impact factor: 3.017

10.  Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score.

Authors:  Sandeep Sahay; Adriano R Tonelli; Mona Selej; Zachary Watson; Raymond L Benza
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.